You are here

Article info

Article menu
Pharmacology and therapeutics
Original research
Adverse drug reactions, multimorbidity and polypharmacy: a prospective analysis of 1 month of medical admissions

Authors

  • Rostam Osanlou Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK Department of Pharmacology and Therapeutics, Liverpool University Hospital Foundation NHS Trust, Liverpool, UK PubMed articlesGoogle scholar articles
  • Lauren Walker Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK Department of Pharmacology and Therapeutics, Liverpool University Hospital Foundation NHS Trust, Liverpool, UK PubMed articlesGoogle scholar articles
  • Dyfrig A Hughes Centre for Health Economics and Medicines Evaluation, Bangor University, Bangor, UK PubMed articlesGoogle scholar articles
  • Girvan Burnside Department of Biostatistics, University of Liverpool, Liverpool, UK PubMed articlesGoogle scholar articles
  • Munir Pirmohamed Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK Department of Pharmacology and Therapeutics, Liverpool University Hospital Foundation NHS Trust, Liverpool, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Munir Pirmohamed; Munirp{at}liverpool.ac.uk
View Full Text

Citation

Osanlou R, Walker L, Hughes DA, et al
Adverse drug reactions, multimorbidity and polypharmacy: a prospective analysis of 1 month of medical admissions
BMJ Open 2022;12:e055551. doi: 10.1136/bmjopen-2021-055551

Publication history

  • Received July 15, 2021
  • Accepted June 22, 2022
  • First published July 4, 2022.
Online issue publication 
July 04, 2022
Previous versions
Review history

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.